Contact
searchSearch
HMP Global

Infectious Diseases Topic Center

Featured Article

Quiz
Insights into the Respiratory Syncytial Virus (RSV) Surge
03/21/2024
03/21/2024
Pharmacy Learning Network
Quiz
Age of RSV Infection Onset in Children
09/22/2023
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all...
09/22/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Finding Novel Therapies for COVID-19
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Losing Options for COVID-19: Monoclonal Antibodies vs Omicron Subvariants
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Interview
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
How to Talk to Patients About the COVID-19 Vaccines
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
News
Countless Homebound Patients Still Wait for COVID-19 Vaccine Despite Priority of Older Adults
02/25/2021
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun...
02/25/2021
Pharmacy Learning Network
Interview
Improving Vaccine Delivery, Operations
02/24/2021
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder,...
02/24/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
Reviewing New COVID Vaccine Data and the Effect on Accessibility
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network
Headshot of Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, on a dark blue background
Podcasts
Ad Council Aims to Help Providers Better Understand Questions Expected About COVID-19 Vaccinations
01/21/2021
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD,...
01/21/2021
Pharmacy Learning Network

Newsfeed

News
How Effective Is the Influenza Vaccine Among Patients With COPD?
01/13/2020
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated...
01/13/2020
Pharmacy Learning Network
News
Factors Contributing to Influenza Vaccine Hesitancy Identified
11/25/2019
Amanda Balbi
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to...
11/25/2019
Pharmacy Learning Network
News
Statins Are Underprescribed, Prescribed at Lower Intensities in Patients With HIV
10/28/2019
Amanda Balbi
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people...
10/28/2019
Pharmacy Learning Network
News
ATS Releases Guidelines On Diagnosing Fungal Infections
09/11/2019
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society...
09/11/2019
Pharmacy Learning Network
PharmLaw
Iowa Attorney General Accuses Insulin Makers and PBMs of Deceptive Pricing Practices
02/03/2026
Juliet Gallagher
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna...
02/03/2026
Pharmacy Learning Network
News
Antacid Tablets Recalled Due to Failed Disintegration Specifications
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
News
Glycopyrrolate Oral Solution Recalled Due to Degradation Specification Failure
01/29/2026
Hannah Musick
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been...
01/29/2026
Pharmacy Learning Network
News
Icosapent Ethyl Capsules Under Class II Recall
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
PharmLaw
PCMA Sues California Over SB 41, Challenging PBM Fiduciary Duties Under ERISA
01/27/2026
Juliet Gallagher
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious...
01/27/2026
Pharmacy Learning Network
News
Recall Issued for Diclofenac Sodium Topical Gel Due to pH Specification Failure
01/22/2026
Grace Taylor, MS, MA
The US Food and Drug Administration (FDA) is overseeing a nationwide, voluntary Class III recall of diclofenac sodium topical gel 1% after the product failed to meet pH specifications, affecting more than 92 000 tubes distributed across the...
The US Food and Drug Administration (FDA) is overseeing a nationwide, voluntary Class III recall of diclofenac sodium topical gel 1% after the product failed to meet pH specifications, affecting more than 92 000 tubes distributed across the...
The US Food and Drug...
01/22/2026
Pharmacy Learning Network
News
Furosemide 40 mg Tablets Recalled Due to Foreign Substance Contamination
01/22/2026
Grace Taylor, MS, MA
The US Food and Drug Administration (FDA) is alerting pharmacists to a voluntary Class II nationwide recall of Furosemide 40 mg tablets after a foreign substance was detected in a distributed lot.
The US Food and Drug Administration (FDA) is alerting pharmacists to a voluntary Class II nationwide recall of Furosemide 40 mg tablets after a foreign substance was detected in a distributed lot.
The US Food and Drug...
01/22/2026
Pharmacy Learning Network
PharmLaw
Compounding Pharmacy Sues Eli Lilly, Novo Nordisk Over Alleged GLP-1 Antitrust Violations
01/21/2026
Juliet Gallagher
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
An Arizona-based compounding...
01/21/2026
Pharmacy Learning Network
News
Imprimis NJOF Initiates Class II Recall of Tri-Moxi+ Intraocular Injection Due to Particulate Matter
01/15/2026
Juliet Gallagher
Imprimis NJOF, LLC is recalling Tri-Moxi+® (Triamcinolone 9 mg/0.6 mL, Moxifloxacin 0.6 mg/0.6 mL) Single-Use Intraocular Injection, NDC 71384-746-06. The recall encompasses 314 boxes totaling 6280 pre-filled syringes. Affected product...
Imprimis NJOF, LLC is recalling Tri-Moxi+® (Triamcinolone 9 mg/0.6 mL, Moxifloxacin 0.6 mg/0.6 mL) Single-Use Intraocular Injection, NDC 71384-746-06. The recall encompasses 314 boxes totaling 6280 pre-filled syringes. Affected product...
Imprimis NJOF, LLC is recalling...
01/15/2026
Pharmacy Learning Network
News
FDA Reports Class II Recall of Imprimis Intraocular Dexamethasone Injections Due to Glass Particulates
01/15/2026
Juliet Gallagher
Imprimis NJOF, LLC is recalling two compounded intraocular injectable drug products distributed nationwide in the US. The first product, Dexamethasone Moxifloxacin Intraocular Injection (1 mg/mL and 5 mg/mL, 1 mL, Rx only; NDC 71384-512-0.1),...
Imprimis NJOF, LLC is recalling two compounded intraocular injectable drug products distributed nationwide in the US. The first product, Dexamethasone Moxifloxacin Intraocular Injection (1 mg/mL and 5 mg/mL, 1 mL, Rx only; NDC 71384-512-0.1),...
Imprimis NJOF, LLC is recalling...
01/15/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Finding Novel Therapies for COVID-19
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Losing Options for COVID-19: Monoclonal Antibodies vs Omicron Subvariants
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Interview
New T-Cell Test to Detect COVID-19 Infection Risk and Sheds Light on the Future of Diagnostic Testing in Health Care
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
How to Talk to Patients About the COVID-19 Vaccines
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
Reviewing New COVID Vaccine Data and the Effect on Accessibility
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network
Headshot of Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, on a dark blue background
Podcasts
Ad Council Aims to Help Providers Better Understand Questions Expected About COVID-19 Vaccinations
01/21/2021
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD,...
01/21/2021
Pharmacy Learning Network
Commentary
A Message of Hope During These Challenging Times
07/20/2020
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through...
07/20/2020
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use